bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide

C14H20F4N3O6S2- — CID 58100504

IUPACbis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide
SMILESO=C(N1CCCCC1)C(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)C(=O)N1CCCCC1
InChIInChI=1S/C14H20F4N3O6S2/c15-13(16,11(22)20-7-3-1-4-8-20)28(24,25)19-29(26,27)14(17,18)12(23)21-9-5-2-6-10-21/h1-10H2/q-1
InChIKeyLZVMSMFLFPQOJO-UHFFFAOYSA-N
MW466.46 g/mol
LogP1.23
Rot. Bonds6

About bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide

bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide (PubChem CID 58100504) has the molecular formula C14H20F4N3O6S2- and a molecular weight of 466.46 g/mol. Its IUPAC name is bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide.

Molecular Properties

Compound Namebis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide
PubChem CID58100504
Molecular FormulaC14H20F4N3O6S2-
Molecular Weight466.46 g/mol
Exact Mass466.07
IUPAC Namebis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide
SMILESO=C(N1CCCCC1)C(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)C(=O)N1CCCCC1
InChIInChI=1S/C14H20F4N3O6S2/c15-13(16,11(22)20-7-3-1-4-8-20)28(24,25)19-29(26,27)14(17,18)12(23)21-9-5-2-6-10-21/h1-10H2/q-1
InChIKeyLZVMSMFLFPQOJO-UHFFFAOYSA-N
XLogP1.23
TPSA123.00 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500466.46
LogP ≤ 51.23
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-[6-[2-[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonylsulfamoyl]-2,2-difluoroacetyl]-1,6-diazacycloundec-1-yl]-1,1-difluoro-2-oxoethyl]sulfonyl-1,1-difluoro-2-oxo-2-piperidin-1-ylethanesulfonamide
CID 88580501
2,2,3,3-tetrafluoro-1,4-di(piperidin-1-yl)butane-1,4-dione
CID 4999121
2,2,3,3,4,4,5,5-octafluoro-1,6-di(piperidin-1-yl)hexane-1,6-dione
CID 3095784
1,5-bis(azepan-1-yl)-2,2,3,3,4,4-hexafluoropentane-1,5-dione
CID 5093018
3,3,3-trifluoro-2-hydroxy-2-methyl-1-piperidin-1-ylpropan-1-one
CID 10751652
2,2-difluoro-1-morpholin-4-yl-2-morpholin-4-ylsulfonylethanone
CID 1356929
2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluoro-1-piperidin-1-ylnonan-1-one
CID 3572182
2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluoro-1-piperidin-1-ylnonan-1-one
CID 3430081
2,2,2-trifluoro-1-[4-(pyrrolidine-1-carbonyl)piperidin-1-yl]ethanone
CID 110344018
3-bromo-2,2-dimethyl-1-pyrrolidin-1-ylpropan-1-one
CID 58931523
1-(azepan-1-yl)-2,2-dimethylbutan-1-one
CID 4631423
2,2,2-trifluoro-1-(4-piperidin-1-ylpiperidin-1-yl)ethanone
CID 24744899

Frequently Asked Questions

What is the IUPAC name of bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide?
The IUPAC name of bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide (CID 58100504) is bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide.
What is the SMILES notation for bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide?
The canonical SMILES for bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide is O=C(N1CCCCC1)C(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)C(=O)N1CCCCC1.
What is the InChIKey of bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide?
The InChIKey is LZVMSMFLFPQOJO-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H20F4N3O6S2/c15-13(16,11(22)20-7-3-1-4-8-20)28(24,25)19-29(26,27)14(17,18)12(23)21-9-5-2-6-10-21/h1-10H2/q-1.
What are the key properties of bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide?
bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide has a molecular weight of 466.46 g/mol, XLogP of 1.23, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for bis[(1,1-difluoro-2-oxo-2-piperidin-1-ylethyl)sulfonyl]azanide is sourced from PubChem (CID 58100504), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).